Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, targeting a $447 ...

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Aurobindo Pharma jumped 3.42% to Rs 1,119.55 after the pharma company said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, reports successful trial results for BP16, a new drug showing promise ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Nifty Pharma index sinks over 2% as Indian drugmakers face tariff heat; Gland, Aurobindo, Biocon, Sun Pharma among top losers ...

Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved ...

Shares of Indian pharma companies with significant US exposure surged by up to 14% after President Trump refrained from imposing new tariffs on the sector. While electronics and gems are hit by ...

Aurobindo Pharma and Gland Pharma have fallen 9 per cent each in the past one week and 22-23 per cent in 2025 so far.

Nifty Pharma fell 6% after Trump hinted at upcoming pharmaceutical tariffs, erasing prior gains. Stocks like IPCA ...